Inhibrx Biosciences, Inc.

INBXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$1.3M

▲ 550.0% YoY

Net Income

-$140.1M

▼ 108.3% YoY

EPS

$-9.04

▼ 108.0% YoY

Cash

$124.2M

▼ 18.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.